Comparative assessment of favipiravir and remdesivir against human coronavirus NL63 in molecular docking and cell culture models

Human coronavirus NL63 (HCoV-NL63) mainly affects young children and immunocompromised patients, causing morbidity and mortality in a subset of patients. Since no specific treatment is available, this study aims to explore the anti-SARS-CoV-2 agents including favipiravir and remdesivir for treating...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yining, Li, Pengfei, Rajpoot, Sajjan, Saqib, Uzma, Yu, Peifa, Li, Yunlong, Li, Yang, Ma, Zhongren, Baig, Mirza S., Pan, Qiuwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8648821/
https://www.ncbi.nlm.nih.gov/pubmed/34873274
http://dx.doi.org/10.1038/s41598-021-02972-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8648821/
https://www.ncbi.nlm.nih.gov/pubmed/34873274
http://dx.doi.org/10.1038/s41598-021-02972-y

Ejemplares similares